Celcuity Inc., a Minneapolis-based biotechnology company, completed its public offering of $575 million of 0.250% convertible senior notes due in 2032. Faegre Drinker represented Celcuity in the offering, providing the company with significant capital.
.svg?rev=0123a45359b34a45b72f615f84c63d11&hash=D9D267D4F8A003D6A105C987E125D147){kind=logo}
